Navigation Links
Centocor Ortho Biotech Inc. Awarded $1.67 Billion Patent Jury Verdict from Abbott Laboratories
Date:6/29/2009

HORSHAM, Pa., June 29 /PRNewswire/ -- Centocor Ortho Biotech Inc. announced today that a federal jury has returned a verdict of $1.67 billion against Abbott Laboratories in a patent infringement suit.

"We are pleased that the jury has ruled in our favor in the patent litigation case against Abbott," said Kim Taylor, President, Centocor Ortho Biotech Inc. The patent in question relates to the company's anti-TNF class of arthritis treatments, and is co-owned by New York University and Centocor, for which Centocor is the exclusive licensee.

"We are particularly gratified that the jury recognized our valuable intellectual property, finding our patent both valid and infringed. We will continue to assert intellectual property rights for our immunology therapies, as they offer significant advances in treatment for patients with a number of immune mediated inflammatory diseases," Taylor added.

About Centocor Ortho Biotech Inc.

Centocor Ortho Biotech Inc. redefines the standard of care in immunology, nephrology, and oncology. The company was created when Ortho Biotech Inc. merged into Centocor, Inc., and Centocor, Inc. was renamed Centocor Ortho Biotech Inc. Built upon a pioneering history, Centocor Ortho Biotech Inc. harnesses innovations in large-molecule and small-molecule research to create important new therapeutic options. Beyond its innovative medicines, Centocor Ortho Biotech is at the forefront of developing education and public policy initiatives to ensure patients and their families, caregivers, advocates, and healthcare professionals have access to the latest treatment information, support services, and quality care. For more information about Centocor Ortho Biotech, visit www.CentocorOrthoBiotech.com. Centocor Ortho Biotech is a wholly-owned subsidiary of Johnson & Johnson.

This
'/>"/>

SOURCE Centocor Ortho Biotech Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Centocor Ortho Biotech Data to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting
2. Baseline Research Indicates High Interest in Centocor-Ortho Biotechs SIMPONI(R)
3. GeneNews provides Centocor access to its osteoarthritis program
4. Ortho Biotech, L.P. and Centocor, Inc. Alert Authorized Distributors and Prescribing Physicians About Stolen Product
5. Centocor, Inc. and Schering-Plough Submit Application Requesting Approval of Golimumab in Europe for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
6. Centocor/Janssen-Cilags Ustekinumab Will Become the Gold Standard for Psoriasis By 2011
7. Centocor Announces Ustekinumab Biologic License Application Accepted for Filing by FDA
8. Medarex Announces Extension of Broad Antibody Development Relationship with Centocor
9. Orthocrat Announces Successful Implementation of TraumaCad at UPMC Mercy
10. Frost & Sullivan Recognizes ApaTechs Leadership in Orthopedic Biologics
11. Pioneer(R) Surgical Technology, Inc. Wins Frost & Sullivans 2009 North American Orthopaedic Tissue Engineering Technology Innovation Award

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... , BOSTON, Nov. 25 Biotech...virus, genomic data from the 1918 pandemic through...rent H1N1 pandemic, today issued its latest bioche...at the lethality of the H1N1 ("Swine Flu") virus h...the virus,s current outbreak in the spring of 2009...
(Date:11/25/2009)... , BEIJING, Nov. 25 /PRNewswire-Asia/...er and provider of vaccines, announced today that ...blish Sinovac (Dalian) Vaccine,Technology Co., Ltd... produce,and commercialize human-use vaccines. Sin...in developing and commercializing world-class vacc...
(Date:11/24/2009)... , HOUSTON, Nov. 24 /PRNewswire-FirstCall/ -...r of electrical and communications systems and ser...al markets, announced today that its commercial bu...attan Torcon JV to install the electrical systems ... facility at the U.S. Army Medical Research Instit...
(Date:11/24/2009)..., CALGARY and BLENHEIM, Ontario, Nov. 24 /PRNew...ced today it is acquiring the assets of Hyland See...ntario. The addition of Hyland Seeds will further ... the company anticipates the introduction of Smar...ide Tolerant Trait Technology in corn in 2012. The...
Breaking Biology Technology:Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Biological H1N1 Vaccines: Too Little, Too Late 5Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3
...HAPEL HILL, N.C., Dec. 11 Health-focused social n...aceutical and biotech companies,biggest challenges...ng,executive from a large biopharmaceutical compan... monitoring and management in "The Crowd,s Noise L...ontent and Enhancing its Impact,on Your Reputation...
...ANSING, Mich., Dec. 11 Neogen Corporation,(Nasdaq...tors has initiated a new,share repurchase program ...common stock. In a joint move, the Board rescinded...ved in 1999. , The shares will be repurchase..., depending on market conditions and other factors...
...AMBURG, Germany, December 11 Olympus has further,...minimally invasive surgery,by signing an exclusive...Irish company Advanced Surgical Concepts worldwide...te-of-the-art laparoscopic operative techniques vi...mpus is now the exclusive,distributor for the full...
Other Biology Technology:Exclusive Conference on Managing Your Online Brand: Shaping the Noise from the Blogosphere 2Neogen Announces New Share Repurchase Program 2Minimally Invasive Surgery: Olympus Further Enhances Credentials by Entering Into Exclusive Sales and Distribution Partnership With Market and Technology Leader Advanced Surgical Concepts 2
(Date:11/24/2009)... today named 12 new grant recipients for 2009. The...ve work across a broad spectrum of lupus research....and potential to drive scientific discovery to ult...se of systemic lupus. , The 2009 grants go to bo...e nation and include interdisciplinary and highly ...
(Date:11/24/2009)...of Medical Toxicology (ACMT) have signed an agreem...nal of Medical Toxicology (JMT), the official jou... previously published by the University of Pennsyl...gy , an international, peer-reviewed journal, is d...medical toxicology. The quarterly journal focuses...
(Date:11/24/2009)...nish . , The presence of increased body fat,...ances in the blood, hinders the loss and maintenan...of the University of Navarra conducted by Estbaliz...rmacy. , The project, entitled "A nutrigenetic a...f body weight and inflammation," examines how the ...
Breaking Biology News(10 mins):Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3Springer and the American College of Medical Toxicology to work together 2It can be predicted the reaction obese patients will have to a diet 2Limb Sparing Surgery May Offer Little Benefit to Cancer Patients 54221 1Limb Sparing Surgery May Offer Little Benefit to Cancer Patients 54221 2Computer system improves pain therapy for cancer patients 54217 1Computer system improves pain therapy for cancer patients 54217 2Aging with GRACE 3A New health care delivery model improves outcomes saves money 54213 1Aging with GRACE 3A New health care delivery model improves outcomes saves money 54213 2Aging with GRACE 3A New health care delivery model improves outcomes saves money 54213 3
...d by Johns Hopkins scientists has,found the first ...mmune,system,s remarkable ability to recognize and...e originated from a family of genes whose,only app...al., "Jumping genes" ,essentially cut themselves o...spected that this ability might have been borrowed...
...City,s Public Health Department today issued a pub...mented case of an alarming, new, rapidly-progressi...w York man who progressed from his initial HIV inf...04, to a largely untreatable strain of AIDS in jus...ls, the man -- who had previously had five negativ...
...e measures are failing to stem the rising rate of ...rial in this week,s BMJ. , An estimated 38 millio...ren, are now infected with HIV, and a record 4.8 m...reason for this continuing increase is socioeconom...prevention, write the authors. , For instance, the...
Other Biology News:New therapy for HIV/AIDS eliminates needles and excessive toxicity 2New therapy for HIV/AIDS eliminates needles and excessive toxicity 3NYC's First Rapid HIV Drug-resistant AIDS Case Prompts Call to Step Up HIV Prevention 2
...r genome-wide microRNA expression profiling and bu...dic on-chip synthesis platform. These microarrays ...A Expression Profiling Service. Probe Content T...microRNAs (108 unique mature sequences). The compr...
Benchtop Laminar Hood (Universal Hood) from Terra Universal, Inc.
...t GC-8A is Shimadzu's basic gas chromatograph mode...e to use, the GC-8A supports a single detector, ma... port(s), and analog output. Isothermal or single ... GC-8A is only 17.3 inches (43.9 cm) wide, yet its...
HCT Plus from Bruker Daltonics
Biology Products: